Leerink Partners on WAVE Life Sciences (WVE) after obesity data disappoints: selloff 'very overdone'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| (NASDAQ: WVE) | Delayed: 3.52 -0.07 (1.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.59 | 52 Week High | $38.50 | |||
| Open | $3.64 | 52 Week Low | $8.95 | |||
| Day High | $3.69 | P/E | N/A | |||
| Day Low | $3.43 | EPS | $0.00 | |||
| Volume | 1,941,393 | |||||
